Yi Xu

4.3k total citations
136 papers, 2.8k citations indexed

About

Yi Xu is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Yi Xu has authored 136 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 64 papers in Cancer Research and 30 papers in Surgery. Recurrent topics in Yi Xu's work include Cancer-related molecular mechanisms research (38 papers), MicroRNA in disease regulation (34 papers) and RNA modifications and cancer (28 papers). Yi Xu is often cited by papers focused on Cancer-related molecular mechanisms research (38 papers), MicroRNA in disease regulation (34 papers) and RNA modifications and cancer (28 papers). Yi Xu collaborates with scholars based in China, Hong Kong and United States. Yi Xu's co-authors include Yunfu Cui, Xingming Jiang, Kaiming Leng, Yue Yao, Xiangyu Zhong, Zhenglong Li, Daolin Ji, Pengcheng Kang, Wei Qin and Lining Huang and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Biochemistry.

In The Last Decade

Yi Xu

127 papers receiving 2.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Xu China 29 2.0k 1.6k 485 308 238 136 2.8k
Da‐Zhi Wang United States 34 3.4k 1.7× 2.0k 1.3× 395 0.8× 392 1.3× 154 0.6× 105 4.5k
Lihua Sun China 32 2.0k 1.0× 1.3k 0.9× 292 0.6× 83 0.3× 209 0.9× 99 3.2k
Shi‐You Chen United States 34 2.0k 1.0× 708 0.5× 469 1.0× 180 0.6× 258 1.1× 128 3.6k
Jianjun Wang China 26 2.0k 1.0× 1.4k 0.9× 184 0.4× 102 0.3× 201 0.8× 92 2.9k
Prasanna Krishnamurthy United States 32 1.9k 0.9× 616 0.4× 513 1.1× 120 0.4× 206 0.9× 74 3.1k
Hui Meng China 26 1.3k 0.7× 851 0.5× 259 0.5× 84 0.3× 180 0.8× 82 2.2k
Yunfei Wang China 35 3.0k 1.5× 2.0k 1.2× 175 0.4× 105 0.3× 440 1.8× 127 4.0k
Sayuri Suzuki Japan 23 1.5k 0.8× 821 0.5× 216 0.4× 112 0.4× 187 0.8× 65 2.5k
Liang Dong China 33 1.6k 0.8× 556 0.4× 486 1.0× 357 1.2× 448 1.9× 85 3.2k

Countries citing papers authored by Yi Xu

Since Specialization
Citations

This map shows the geographic impact of Yi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xu more than expected).

Fields of papers citing papers by Yi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xu. The network helps show where Yi Xu may publish in the future.

Co-authorship network of co-authors of Yi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xu. A scholar is included among the top collaborators of Yi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xu. Yi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Shanshan, Zhiyu Wang, Junting Zhou, et al.. (2025). Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications. Journal of Clinical and Translational Hepatology. 0(0). 0–0.
3.
Ge, Yifei, et al.. (2024). Exosome-mediated Crosstalk in the Tumor Immune Microenvironment: Critical Drivers of Hepatocellular Carcinoma Progression. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 4 indexed citations
4.
Liu, Liru, Yuan Huang, Tingting Peng, et al.. (2023). Potential optimized route for mesenchymal stem cell transplantation in a rat model of cerebral palsy. Experimental Cell Research. 430(2). 113734–113734. 3 indexed citations
6.
Yao, Yue, Yi Xu, Liang Yu, et al.. (2023). NHE7 upregulation potentiates the uptake of small extracellular vesicles by enhancing maturation of macropinosomes in hepatocellular carcinoma. Cancer Communications. 44(2). 251–272. 6 indexed citations
7.
Xu, Yi, Yue Yao, Liang Yu, et al.. (2023). Clathrin light chain A‐enriched small extracellular vesicles remodel microvascular niche to induce hepatocellular carcinoma metastasis. Journal of Extracellular Vesicles. 12(8). e12359–e12359. 15 indexed citations
8.
Xu, Yi, Yue Yao, Liang Yu, et al.. (2023). Clathrin light chain A facilitates small extracellular vesicle uptake to promote hepatocellular carcinoma progression. Hepatology International. 17(6). 1490–1499. 7 indexed citations
9.
Wang, Yudan, Haoming Xia, Shuqiang Liu, et al.. (2023). Roles and Molecular Mechanisms of Biomarkers in Hepatocellular Carcinoma with Microvascular Invasion: A Review. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 14 indexed citations
10.
Tey, Sze Keong, Samuel W. K. Wong, Xiaowen Mao, et al.. (2022). Actin-related protein 2/3 complex subunit 2-enriched extracellular vesicles drive liver cancer metastasis. Hepatology International. 16(3). 603–613. 6 indexed citations
11.
12.
Huang, Ziyue, Haoming Xia, Yunfu Cui, Judy Wai Ping Yam, & Yi Xu. (2022). Ferroptosis: From Basic Research to Clinical Therapeutics in Hepatocellular Carcinoma. Journal of Clinical and Translational Hepatology. 0(0). 0–0. 25 indexed citations
13.
Wang, Hang, Liang Yu, Peng Huang, et al.. (2022). Tumor-associated Exosomes Are Involved in Hepatocellular Carcinoma Tumorigenesis, Diagnosis, and Treatment. Journal of Clinical and Translational Hepatology. 10(3). 496–508. 13 indexed citations
14.
Zhang, Shuai, Siyu Huang, Lu Zeng, et al.. (2021). AhR/miR-23a-3p/PKCα axis contributes to memory deficits in ovariectomized and normal aging female mice. Molecular Therapy — Nucleic Acids. 24. 79–91. 17 indexed citations
15.
Liu, Bonnie Hei Man, Sze Keong Tey, Xiaowen Mao, et al.. (2021). TPI1‐reduced extracellular vesicles mediated by Rab20 downregulation promotes aerobic glycolysis to drive hepatocarcinogenesis. Journal of Extracellular Vesicles. 10(10). e12135–e12135. 38 indexed citations
16.
Zheng, Wangyang, Daolin Ji, Yongxu Zhou, et al.. (2021). Exosomal Noncoding RNAs in Hepatobiliary Cancer: A Rising Star. Molecular Cancer Therapeutics. 20(10). 1777–1788. 3 indexed citations
17.
Yao, Jiayu, et al.. (2019). Evaluation and characteristic analysis of SSRs from the whole genome of jute (Corchorus capsularis). ACTA AGRONOMICA SINICA. 45(1). 10–17. 3 indexed citations
18.
Zhang, Yu, Lixin Sun, Hongwei Zhao, et al.. (2017). Application of human papillomavirus 16/18 E6 protein detection for cervical cancer screening. 29(3). 164–167. 1 indexed citations
19.
Li, Wenqing, Nan Hu, Howard H. Yang, et al.. (2014). PLCE1 mRNA and Protein Expression and Survival of Patients with Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma. Cancer Epidemiology Biomarkers & Prevention. 23(8). 1579–1588. 26 indexed citations
20.
Wang, Jialin, et al.. (2005). Effect of common gurmeric on vascular endothelial growth factor and microvessel density in a thymic mouse model transplanted with human gastric carcinoma. Tumori. 25(1). 55–57. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026